arrow
Back
S

Stephen M. Ansell

mayo clinic

111H-index
1.5KPaper Count
5.2WCitation Count
Published Papers 296
Publication Date
Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer database analysis
err2026-06-03
err0
errOAAI
errJulia Wang; Yajuan Gao; N. Nora Bennani; Yun Kyoung Tiger; Arushi Khurana; Urshila Durani; Jonas Paludo; Gita Thanarajasingam; Steven R. Hwang; Yucai Wang; Grzegorz S. Nowakowski; Thomas M. Habermann; Thomas E. Witzig; Stephen M. Ansell; Jithma P. Abeykoon
errShare
errSave
Racial/Ethnic Disparities in Neoplasm-Related Mortality and the Social Determinants of Health
errCancers
IF4.4
err2026-05-13
err0
errOAAI
errYoshito Nishimura; Mariko Fujii; Nanami Sako; Quynh Thi Vu; Ko Harada; Hideharu Hagiya; Urshila Durani; Stephen M. Ansell; James R. Cerhan; Toshihiro Koyama
errShare
errSave
Treatment of Diffuse Large B-Cell Lymphoma
err2026-04-10
err0
PREAI
errAyo S. Falade; Stephen M. Ansell
errShare
errSave
Lymphocyte dynamics after CAR-T therapy for non-Hodgkin lymphoma
err2026-04-01
err0
PREAI
errDingli, Sarah; Rothweiler, Paul; Corraes, Andre De Menezes Silva; Atallah-Yunes, Albert; Ansell, Stephen M.; Bennani, N. Nora; Durani, Urshila; Johnston, Patrick B.; Khurana, Arushi; Paludo, Jonas; Bisneto, J. C. Villasboas; Wang, Yucai; Lin, Yi; Erdman, Arthur G.; Dingli, David
errShare
errSave
High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma Subtypes
err2026-03-27
err0
PREAI
errArushi Khurana; Hikaru Hayashi; Bethany Thach; Zhi Zhang Yang; Brianna J. Negaard; James R. Cerhan; Anne J. Novak; Brian K. Link; Thomas M. Habermann; Andrew L. Feldman; Sameer A. Parikh; Susan L. Slager; Stephen M. Ansell; Matthew J. Maurer; Denise L. Faustman
errShare
errSave
Current treatment algorithm: diffuse large B cell lymphoma
err2026-03-10
err0
errOAAI
errStephen M. Ansell; Grzegorz S. Nowakowski
errShare
errSave
Malignant B cells expressing SIRPα are highly proliferative and are associated with inferior clinical outcomes in B-cell non-Hodgkin lymphoma
errLeukemia
IF13.4
err2026-02-04
err0
PREAI
errZhi-Zhang Yang; Hyo Jin Kim; Xinyi Tang; Joseph P. Novak; Vaishali Bhardwaj; Prithviraj Mukherjee; Jose C. Villasboas; Anne J. Novak; Patrizia Mondello; Stephen M. Ansell
errShare
errSave
PD-1-based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin Lymphoma
errBlood
IF23.1
err2025-12-19
err0
PREAI
errSanjal H. Desai; Alison J. Moskowitz; Reid W. Merryman; Harsh Shah; Levi D. Pederson; Susan M. Geyer; Nivetha Ganesan; Tiffany Chang; Tamer Othman; Ayo S Falade; Gunjan L. Shah; Urshila Durani; Nuttavut Sumransub; Lay She Ng; Kelsey Baron; Shin Yeu Ong; Kevin Yoon; Stephen M Ansell; Philippe Armand; Siddharth Iyengar
errShare
errSave
Consensus Recommendations from the 2024 International Follicular Lymphoma Scientific Workshop
err2025-12-05
err0
errOAAI
errReid Merryman; Sarah C. Rutherford; Stephen Ansell; Philippe Armand; John P. Leonard; Loretta Nastoupil; Sonali M. Smith; John Timmerman; Andrew D. Zelenetz; Meghan Gutierrez; Wendy Béguelin; Carla Casulo; James Cerhan; Michael Green; Brad Kahl; Robert Kridel; Brian Link; Matthew J. Maurer; Bertrand Nadel; Andrea J. Radtke
errShare
errSave
Treatment approaches and clinical outcomes in primary colorectal MALT lymphoma: a single-institution retrospective study of 66 patients
err2025-12-01
err0
errOAAI
errAtallah-Yunes, Suheil Albert; Rees, Matthew J.; Habermann, Thomas M.; Wang, Yucai; Munoz, Javier; Iqbal, Madiha; Villasboas, Jose C.; McPhail, Ellen D.; Witzig, Thomas E.; Ansell, Stephen M.; Nowakowski, Grzegorz S.
errShare
errSave
The ratio of brain to liver glucose activity and prognosis with CAR-T in non-Hodgkin lymphoma
err2025-11-23
err0
errOAAI
errSarah Dingli; Paul Rothweiler; Stephen M. Ansell; N. Nora Bennani; Urshila Durani; Patrick B. Johnston; Arushi Khurana; Jonas Paludo; J. C. Villasboas Bisneto; Yucai Wang; Yi Lin; Jason R. Young; Stephen M. Broski; Arthur G. Erdman; David Dingli
errShare
errSave
IRF4 controls immune and metabolic signaling with functional effects on the crosstalk between B and T cells
err2025-11-01
err0
PREAI
errMondello, Patrizia; Mukherjee, Prithviraj; Bhardwaj, Vaishali; Tang, Xinyi; Hachfeld, Christine; Yang, Zhi-Zhang; Landau, Judith; Weivoda, Megan; Graham, Nicholas A.; Shlomchik, Mark J.; Singh, Harinder; Ansell, Stephen
errShare
errSave
Cytokine-inducible SH2-containing protein (CISH) is an intracellular immune checkpoint that controls T regulatory cells in Splenic Marginal Zone Lymphoma
err2025-11-01
err0
PREAI
errTang, Xinyi; Yang, Zhi-Zhang; Yu, Yue; Wu, Xiaosheng; Bhardwaj, Vaishali; Mukherjee, Prithviraj; Mondello, Patrizia; Kim, Hyo Jin; Novak, Anne Josephine; Ansell, Stephen Maxted
errShare
errSave
B cells expressing SIRPα are highly proliferative and are associated with inferior clinical outcomes in B-cell non-Hodgkin lymphoma
err2025-11-01
err0
PREAI
errYang, Zhi-Zhang; Kim, Hyojin; Tang, Xinyi; Novak, Joseph P.; Bhardwaj, Vaishali; Mukherjee, Prithviraj; Villasboas, Jose C.; Novak, Anne Josephine; Mondello, Patrizia; Ansell, Stephen
errShare
errSave
Investigating polyclonal Follicular Lymphoma tumors to determine the inciting factors for lymphomagenesis
err2025-11-01
err0
PREAI
errSiminski, Miranda S.; Krull, Jordan; Novak, Joe; Dropik, Abigail; Walker, Janek; Wenzl, Kerstin; Xianyu, Zilin; Maurer, Matthew; Rimsza, Lisa; Delbusso, Miles; Ansell, Stephen; Cerhan, James; Novak, Anne Josephine
errShare
errSave
Multi-Institutional Study of ALK-Positive Large B-Cell Lymphoma: Outcomes in the Era of ALK Inhibitors and Biologically Informed Therapies
err2025-09-03
err0
PREAI
errSuheil Albert Atallah-Yunes; Chijioke C. Nze; Rebecca L. King; Matthew J. Rees; Juan Pablo Alderuccio; Marcus Watkins; Brad S. Kahl; Neela Easwar; Samuel Yamshon; Aditya Ravindra; Umar Farooq; Allison C. Rosenthal; Javier L. Munoz; Estela M. Rojas-Neira; Amy A. Ayers; Muhamad Alhaj Moustafa; Thomas M. Habermann; Thomas E. Witzig; Stephen M. Ansell; Grzegorz S. Nowakowski; Jean L. Koff; Christopher R. Flowers; Yucai Wang
errShare
errSave
Tumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma
err2025-08-27
err0
errOAAI
errHui Wan; Weicheng Ren; Mingyu Yang; Man Nie; Agata M. Wasik; Likun Du; Leire de Campos-Mata; Rui Sun; Zhiliang Bai; Archibald Enninful; Yating Wang; Mattias Berglund; Rose-Marie Amini; Xiaobo Li; Chunli Yang; Xiaofei Ye; Zhi-Zhang Yang; Stephen M. Ansell; Dongbing Liu; Mirjam van der Burg; Rong Fan; Kui Wu; Birgitta Sander; Qiang Pan-Hammarström
errShare
errSave
Unraveling lymphoma-induced immune senescence
err2025-08-21
err0
PREAI
errPatrizia Mondello; Stephen M. Ansell
errShare
errSave
Camidanlumab Tesirine in Relapsed or Refractory Classic Hodgkin Lymphoma: A Phase 2 Study
err2025-08-19
err0
errOAAI
errAlex F. Herrera; Stephen M. Ansell; Pier Luigi Zinzani; John Radford; Kami Maddocks; Antonio Pinto; Graham P. Collins; Veronika Bachanova; Nancy L. Bartlett; Isabelle Bence-Bruckler; Mehdi Hamadani; Justin Kline; Jiří Mayer; Kerry J. Savage; Ranjana H. Advani; Paolo F. Caimi; René-Olivier Casasnovas; Tatyana Feldman; Brian Hess; Mariana Bastos-Oreiro
errShare
errSave
Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohorts
err2025-08-08
err0
errOAAI
errPatrizia Mondello; Brianna Negaard; Andrew L. Feldman; Brian K. Link; Carla Casulo; Dai Chihara; David Russler-Germain; Jason Romancik; Caitlin Gribbin; Sara Haddadi; Eric Mou; Ivana N. Micallef; Patrick B. Johnston; Joseph Novak; Yucai Wang; Rebecca L. King; Anne J. Novak; Thomas M. Habermann; Peter Martin; Brad Kahl; Grzegorz S. Nowakowski; Loretta J. Nastoupil; James R. Cerhan; Christopher R. Flowers; Izidore S. Lossos; Richard W. Burack; Matthew J. Maurer; Stephen M. Ansell
errShare
errSave